The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil

被引:30
作者
Gao, Ying
Chen, Min
Ye, Hua
Guo, Xiao-Hui
Zhao, Ming-hui [1 ]
Wang, Hai-yan
机构
[1] Peking Univ, First Hosp, Dept Nephrol, Beijing 100034, Peoples R China
[2] Peking Univ, First Hosp, Dept Endocrinol, Beijing 100034, Peoples R China
基金
中国国家自然科学基金;
关键词
antineutrophil cytoplasmic antibodies; vasculitis; propylthiouracil; hyperthyroidism; target antigen;
D O I
10.1016/j.intimp.2006.07.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: Antineutrophil cytoplasmic antibody (ANCA) has been well documented in association with propylthiouracil (PTU), and some patients with PTU-induced ANCA also develop clinical vasculitis. The aim of the current study was to detect ANCA specificities in sera from patients with PTU-induced ANCA with and without clinical vasculitis. Methods: Sera from 65 patients with PTU-induced ANCA were collected, and 27 of these patients were diagnosed with PTU-induced ANCA associated systemic vasculitis (AASV). Indirect immunofluorescence assay and antigen-specific ELISAs were used to detect ANCA and their antigen specificities. The seven known target antigens included myeloperoxidase (MPO), protemase 3, human leukocyte elastase, lactoferrin, cathepsin G, azurocidin and bactericidal/pen-neability-increasing protein (BPI). Results: In IIF assay, P-ANCA was found in 58/65 (89.2%) sera, C-ANCA in two, both P-ANCA and C-ANCA in five, respectively. MPO (60%) and lactoferrin (63.1%) were the two most common target antigens detected in sera from all the patients. 25/27 sera from patients with PTU-induced AASV recognized multiple target antigens, which was significantly higher than those (13/38) from patients without (P < 0.001). Except anti-BPI antibodies, the prevalence of antibodies against the other six target antigens was significantly higher in patients with clinical vasculitis than that in patients without (P < 0.05, respectively). Conclusion: Antibodies against multiple ANCA specific antigens, especially the antigens rather than MPO and PR3, might be the characteristic of PTU-induced ANCA. Patients with antibodies against more ANCA specific antigens might be at increased risk of developing overt clinical vasculitis. The mechanism of ANCA production in PTU-induced cases was different from that in primary AASV (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 24 条
[1]   NEUTROPHIL DE-GRANULATION INHIBITS POTENTIAL HYDROXYL-RADICAL FORMATION - RELATIVE IMPACT OF MYELOPEROXIDASE AND LACTOFERRIN RELEASE ON HYDROXYL-RADICAL PRODUCTION BY IRON-SUPPLEMENTED NEUTROPHILS ASSESSED BY SPIN-TRAPPING TECHNIQUES [J].
BRITIGAN, BE ;
HASSETT, DJ ;
ROSEN, GM ;
HAMILL, DR ;
COHEN, MS .
BIOCHEMICAL JOURNAL, 1989, 264 (02) :447-455
[2]   Drug therapy: Antithyroid drugs [J].
Cooper, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09) :905-917
[3]   VASCULITIS AND ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES ASSOCIATED WITH PROPYLTHIOURACIL THERAPY [J].
DOLMAN, KM ;
GANS, ROB ;
VERVAAT, TJ ;
ZEVENBERGEN, G ;
MAINGAY, D ;
NIKKELS, RE ;
DONKER, AJM ;
BORNE, AEGKV ;
GOLDSCHMEDING, R .
LANCET, 1993, 342 (8872) :651-652
[4]   The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism [J].
Gao, Y ;
Zhao, MH ;
Guo, XH ;
Xin, G ;
Gao, Y ;
Wang, HY .
ENDOCRINE RESEARCH, 2004, 30 (02) :205-213
[5]   Anti-thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis. A case report and review of the literature [J].
Gunton, JE ;
Stiel, J ;
Caterson, RJ ;
McElduff, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :13-16
[6]   Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis [J].
Hagen, EC ;
Daha, MR ;
Hermans, J ;
Andrassy, K ;
Csernok, E ;
Gaskin, G ;
Lesavre, P ;
Lüdemann, J ;
Rasmussen, N ;
Sinico, RA ;
Wiik, A ;
van der Woude, FJ .
KIDNEY INTERNATIONAL, 1998, 53 (03) :743-753
[7]  
Harper L, 2000, J PATHOL, V190, P349, DOI 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO
[8]  
2-A
[9]   Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease [J].
Harper, L ;
Chin, L ;
Daykin, J ;
Allahabadia, A ;
Heward, J ;
Gough, SC ;
Savage, CO ;
Franklyn, JA .
CLINICAL ENDOCRINOLOGY, 2004, 60 (06) :671-675
[10]   ACCUMULATION OF PROPYLTHIOURACIL-2-C-14 IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
LAM, DCC ;
LINDSAY, RH .
BIOCHEMICAL PHARMACOLOGY, 1979, 28 (15) :2289-2296